Smoking and myocardial infarction case-fatality: Hospital and population approach

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 14, Issue 4, 2007, Pages 561-567

  Elosua, Roberto ^a   Vega, Gema ^b   Rohlfs, Izabella ^c   Aldasoro, Elena ^d   Navarro, Carmen ^e   Cabades, Adolfo ^f   Demissie, Serkalem ^g   Segura, Antonio ^h   Fiol, Miquel ⁱ   Moreno Iribas, Concepción ^j   Echanove, Ildefonso ^k   Tormo, María José ^e   Arteagoitia, José María ^d   Sala, Joan ^c   Marrugat, Jaume ^a,l  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b Hospital de Albacete   (Spain)

^c Hospital Universari Josep Trueta   (Spain)

^d DEPARTMENT OF HEALTH   (Spain)

^e Regional Health Autority   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^h Health Sciences Institute

ⁱ Institut Universitari d'Investigacio en Ciencies de la Salut IUNICS   (Spain)

^j INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^k Valencia General Hospital   (United States)

^l UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

more..

Author keywords

Case fatality; Mortality; Myocardial infarction; Registry; Smoking

Indexed keywords

ADULT; AGED; ARTICLE; CASE FATALITY ANALYSIS; COMORBIDITY; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; POPULATION RESEARCH; POPULATION RISK; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SPAIN;

AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; RISK FACTORS; SMOKING; SPAIN;

EID: 34547814062     PISSN: 17418267     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32804955b3     Document Type: Article

References (27)

1. Lakier JB. Smoking and cardiovascular disease. Am J Med 1992; 93:S8-S12.
2. Doll R, Peto R, Weatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observation on male British doctors. BMJ 1994; 309:901-911.
3. Wilson K, Gibson N, Willian A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000; 160:939-944.
4. Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993; 87:53-58.
5. Barbash GI, Reiner J, White HD, Wilcox RG, Armstrong PW, Sadowski Z, et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the 'smoker's paradox' from the GUSTO-I trial, with angiographic insights. Global utilization of streptokinase and tissue-plasminogen activator for occluded coronary arteries. J Am Coll Cardiol 1995; 26:1222-1229.
6. Gottlieb S, Boyko V, Zahger D, Balkin J, Hod H, Pelled B, et al. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). J Am Coll Cardiol 1996; 28:1506-1513.
7. Andrikopoulos GK, Richter DJ, Dilaveris PE, Pipilis A, Zaharoulis A, Gialafos JE, et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the 'smoker's paradox' in a countrywide study. Eur Heart J 2001; 22:776-784.
8. Gourlay SG, Rundle AC, Barron HV. Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2). Nicotine Tob Res 2002; 4:101-107.
9. Ruiz-Bailen M, de Hoyos EA, Reina-Toral A, Torres-Ruiz JM, Alvarez-Bueno M, Gomez-Jimenez FJ. Paradoxical effect of smoking in the Spanish population with acute myocardial infarctionn or unstable angina: results of the ARIAM Register. Chest 2004; 125:831-840.
10. Himbert D, Klutman M, Steg G,White K, Gulba DC. Cigarrette smoking and acute coronary syndromes: a multinational observational study. Int J Cardiol 2005; 100:109-117.
11. De Chillou C, Riff P, Sadoul N, Ethevenot G, Feldmann L, Isaaz K. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis. J Am Coll Cardiol 1996; 27:1662-1668.
12. Chambless L, Keil U, Dobson A, Mahonen M, Kuulasmaa K, Rajakangas AM, et al. Population vesus clinical view of case fatality from acute coronary heart disease. Results from the WHO MONICA Project 1985-1990. Circulation 1997; 96:3849-3859.
13. Marrugat J, Elosua R, Aldasoro E, Tormo JM, Vanaclocha H, Segura A, et al. Regional variability in population acute myocardial infarction cumulative incidence and mortality rates in Spain 1997 and 1998. Eur J Epidemiol 2004; 19:831-839.
14. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arvelier D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90:583-612.
15. Allison PD. Missing data. Sage university papers series on quantitative applications in the social sciences, 07-136. Thousand Oaks, California: Sage; 2001.
16. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, et al. Clinical implications of cigarette smoking in acute myocardial infarction: acute angiographic findings and long-term prognosis. Am Heart J 1997; 134:955-960.
17. Grines CL, Topol EJ, O'Neill WW, George BS, Kereiakes D, Phillips HR, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995; 91:298-303.
18. Barua RS, Ambrose JA, Saha DC, Eagles-Reynolds LJ. Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: an in vitro demonstration. Circulation 2002; 106:905-908.
19. Newby DE, McLeod AL, Uren NG, Flint L, Ludlam CA, Webb DJ, et al. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Circulation 2001; 103:1936-1941.
20. Kennon S, Barakat K, Suliman A, MacCallum PK, Ranjadayalan K, Wilkinson P, et al. Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction. Heart 2000; 84:41-45.
21. Lundergan CF, Reiner JS, McCarthy WF, Coyne KS, Califf RM, Ross AM, et al. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global utilization of streptokinase and t-PA for occluded coronary arteries. J Am Coll Cardiol 1998; 32:641-647.
22. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336:1276-1282.
23. Sonke GS, Stewart AW, Beaglehole R, Jackson R, White AD. Comparison of case fatality in smokers and non-smokers after acute cardiac event. BMJ 1997; 315:992-993.
24. McElduff P, Dobson AJ. Case fatality after an acute cardiac event: the effect of smoking and alcohol consumption. J Clin Epidemiol 2001; 54:58-67.
25. Noda T, Minatoguchi S, Fujii K, Hori M, Ito T, Kanmatsuse K, et al. Evidence for the delayed effect in human ischemic preconditioning: prospective multicenter study for preconditioning in acute myocardial infarction. J Am Coll Cardiol 1999; 34:1966-1974.
26. Kuller L, Meilahn E, Townsend M, Weinberg G. Control of cigarette smoking from a medical perspective. Annu Rev Public Health 1982; 3:153-178.
27. Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 1994; 84:1086-1093.